{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:45:44Z","timestamp":1788363944871,"version":"build-2803163510"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2019GSF108265"],"award-info":[{"award-number":["2019GSF108265"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hypopharyngeal squamous cell carcinoma (HSCC) is a common malignant\ncancer characterized by high metastasis and infiltration. The development of new approaches for the\nearly diagnosis and identification of new therapeutic targets is essential. TIPE2 is well known as a tumor\nsuppressor and related to a favorable prognosis of HSCC. However, its underlying mechanism\nremains unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods and Materials:<\/jats:title>\n<jats:p>TIPE2 expression was determined by immunohistochemistry and RT-qPCR.\nA TIPE2 overexpression stable cell line was generated by lentivirus infection. TIPE2 and other related\nprotein levels were detected by western blotting. The cell cycle and apoptosis were performed by flow\ncytometric analysis. Cell proliferation was measured with a Cell Counting Kit-8 (CCK-8) assay, and\nthe activity of caspase-3 and caspase-7 was assessed by Caspase-Glo\u00ae 3\/7 Assay. All data were analyzed\nwith SPSS 25 and GraphPad Prism 8.0.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>TIPE2 expression was significantly down-regulated in HSCC. Low TIPE2 expression may be\nassociated with poor prognosis in HSCC. TIPE2 overexpression markedly inhibited tumor cell migration.\nMoreover, TIPE2 decreased cell proliferation but promoted apoptosis. TIPE2 suppressed tumor\ngrowth by activating Epithelial-Mesenchymal Transition (EMT) and the extrinsic apoptosis pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>TIPE2 inhibited tumor progression by suppressing cell migration but promoting apoptosis.\nTIPE2 can be a new therapeutic target in HSCC.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389203723666220727090317","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T12:01:35Z","timestamp":1658923295000},"page":"424-436","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TIPE2 Inhibits Migration and Promotes Apoptosis as a Tumor Suppressor\nin Hypopharyngeal Carcinoma"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6880-7084","authenticated-orcid":true,"given":"Juan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfa","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongdong","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangmei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China"},{"name":"NHC Key Laboratory of\nOtorhinolaryngology, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"Siegel R.L.","year":"2021","unstructured":"Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2021. CA Cancer J Clin 2021,71(1),7-33","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN esti-mates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells8010009","volume":"8","author":"Niture S.","year":"2018","unstructured":"Niture S.; Dong X.; Arthur E.; Chimeh U.; Niture S.S.; Zheng W.; Kumar D.; Oncogenic role of tumor necrosis factor \u03b1-induced pro-tein 8 (TNFAIP8). Cells 2018,8(1),9","journal-title":"Cells"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"eabi6515","DOI":"10.1126\/sciadv.abi6515","volume":"7","author":"Bi J.","year":"2021","unstructured":"Bi J.; Cheng C.; Zheng C.; Huang C.; Zheng X.; Wan X.; Chen Y.H.; Tian Z.; Sun H.; TIPE2 is a checkpoint of natural killer cell matu-ration and antitumor immunity. Sci Adv 2021,7(38),eabi6515","journal-title":"Sci Adv"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"112631","DOI":"10.1016\/j.yexcr.2021.112631","volume":"404","author":"Sun X.","year":"2021","unstructured":"Sun X.; Li X.; Zhou Y.; Wang Y.; Liu X.; Up-regulating TIPE2 alleviates inflammatory pain by suppressing microglial activation-mediated inflammatory response via inhibiting Rac1\/NF-\u03baB pathway. Exp Cell Res 2021,404(1),112631","journal-title":"Exp Cell Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: The next generation. Cell 2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1080\/15548627.2020.1761748","volume":"17","author":"Li W.","year":"2021","unstructured":"Li W.; Li Y.; Guan Y.; Du Y.; Zhao M.; Chen X.; Zhu F.; Guo C.; Jia Y.; Li Y.; Wang X.; Wang X.; Shi Y.; Wang Q.; Li Y.; Zhang L.; TNFAIP8L2\/TIPE2 impairs autolysosome reformation via modulating the RAC1-MTORC1 axis. Autophagy 2021,17(6),1410-1425","journal-title":"Autophagy"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1476-4598-12-149","volume":"12","author":"Cao X.","year":"2013","unstructured":"Cao X.; Zhang L.; Shi Y.; Sun Y.; Dai S.; Guo C.; Zhu F.; Wang Q.; Wang J.; Wang X.; Chen Y.H.; Zhang L.; Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 2013,12(1),149","journal-title":"Mol Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"62224","DOI":"10.18632\/oncotarget.11406","volume":"7","author":"Li Z.","year":"2016","unstructured":"Li Z.; Guo C.; Liu X.; Zhou C.; Zhu F.; Wang X.; Wang Q.; Shi Y.; Wang J.; Zhao W.; Zhang L.; TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression. Oncotarget 2016,7(38),62224-62239","journal-title":"Oncotarget"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"Yang J.","year":"2020","unstructured":"Yang J.; Antin P.; Berx G.; Blanpain C.; Brabletz T.; Bronner M.; Campbell K.; Cano A.; Casanova J.; Christofori G.; Dedhar S.; Derynck R.; Ford H.L.; Fuxe J.; Garc\u00eda de Herreros A.; Goodall G.J.; Hadjantonakis A.K.; Huang R.Y.J.; Kalcheim C.; Kalluri R.; Kang Y.; Khew-Goodall Y.; Levine H.; Liu J.; Longmore G.D.; Mani S.A.; Massagu\u00e9 J.; Mayor R.; McClay D.; Mostov K.E.; New-green D.F.; Nieto M.A.; Puisieux A.; Runyan R.; Savagner P.; Stanger B.; Stemmler M.P.; Takahashi Y.; Takeichi M.; Theveneau E.; Thiery J.P.; Thompson E.W.; Weinberg R.A.; Williams E.D.; Xing J.; Zhou B.P.; Sheng G.; Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2020,21(6),341-352","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"Dongre A.","year":"2019","unstructured":"Dongre A.; Weinberg R.A.; New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 2019,20(2),69-84","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.devcel.2015.06.012","volume":"34","author":"Scarpa E.","year":"2015","unstructured":"Scarpa E.; Szab\u00f3 A.; Bibonne A.; Theveneau E.; Parsons M.; Mayor R.; Cadherin switch during EMT in neural crest cells leads to con-tact inhibition of locomotion via repolarization of forces. Dev Cell 2015,34(4),421-434","journal-title":"Dev Cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","volume":"21","author":"Stemmler M.P.","year":"2019","unstructured":"Stemmler M.P.; Eccles R.L.; Brabletz S.; Brabletz T.; Non-redundant functions of EMT transcription factors. Nat Cell Biol 2019,21(1),102-112","journal-title":"Nat Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.devcel.2020.06.021","volume":"54","author":"Li Y.","year":"2020","unstructured":"Li Y.; Lv Z.; Zhang S.; Wang Z.; He L.; Tang M.; Pu W.; Zhao H.; Zhang Z.; Shi Q.; Cai D.; Wu M.; Hu G.; Lui K.O.; Feng J.; Nieto M.A.; Zhou B.; Genetic fate mapping of transient cell fate reveals N-cadherin activity and function in tumor metastasis. Dev Cell 2020,54(5),593-607.e5","journal-title":"Dev Cell"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.1073\/pnas.1108977108","volume":"108","author":"S\u00e1nchez-Till\u00f3 E.","year":"2011","unstructured":"S\u00e1nchez-Till\u00f3 E.; de Barrios, O.; Siles, L.; Cuatrecasas, M.; Castells, A.; Postigo, A. \u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA 2011,108(48),19204-19209","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1004900107","volume":"107","author":"Taube J.H.","year":"2010","unstructured":"Taube J.H.; Herschkowitz J.I.; Komurov K.; Zhou A.Y.; Gupta S.; Yang J.; Hartwell K.; Onder T.T.; Gupta P.B.; Evans K.W.; Holli-er B.G.; Ram P.T.; Lander E.S.; Rosen J.M.; Weinberg R.A.; Mani S.A.; Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010,107(35),15449-15454","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ijbiomac.2019.07.113","volume":"138","author":"Dhuriya Y.K.","year":"2019","unstructured":"Dhuriya Y.K.; Sharma D.; Naik A.A.; Cellular demolition: Proteins as molecular players of programmed cell death. Int J Biol Macromol 2019,138,492-503","journal-title":"Int J Biol Macromol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"Kesavardhana S.","year":"2020","unstructured":"Kesavardhana S.; Malireddi R.K.S.; Kanneganti T.D.; Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol 2020,38,567-595","journal-title":"Annu Rev Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/embj.201385686","volume":"33","author":"Kranz D.","year":"2014","unstructured":"Kranz D.; Boutros M.; A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. EMBO J 2014,33(3),181-197","journal-title":"EMBO J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.cdd.4401062","volume":"9","author":"Pirnia F.","year":"2002","unstructured":"Pirnia F.; Schneider E.; Betticher D.C.; Borner M.M.; Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspa-se-3 and Fas-independent pathway. Cell Death Differ 2002,9(9),905-914","journal-title":"Cell Death Differ"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"Fritsch M.","year":"2019","unstructured":"Fritsch M.; G\u00fcnther S.D.; Schwarzer R.; Albert M.C.; Schorn F.; Werthenbach J.P.; Schiffmann L.M.; Stair N.; Stocks H.; Seeger J.M.; Lamkanfi M.; Kr\u00f6nke M.; Pasparakis M.; Kashkar H.; Caspase-8 is the molecular switch for apoptosis, necroptosis and pyropto-sis. Nature 2019,575(7784),683-687","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","volume":"574","author":"Newton K.","year":"2019","unstructured":"Newton K.; Wickliffe K.E.; Dugger D.L.; Maltzman A.; Roose-Girma M.; Dohse M.; K\u0151m\u0171ves, L.; Webster, J.D.; Dixit, V.M. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature 2019,574(7778),428-431","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"680985","DOI":"10.3389\/fonc.2021.680985","volume":"11","author":"Feng F.","year":"2021","unstructured":"Feng F.; Liu C.; Bian H.; Cai W.; Zhou Y.; Zhou L.; Zhuang Z.; TIPE2 suppresses malignancy of pancreatic cancer through inhibiting TGF\u03b21 mediated signaling pathway. Front Oncol 2021,11,680985","journal-title":"Front Oncol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"669199","DOI":"10.3389\/fphar.2021.669199","volume":"12","author":"Liu W.","year":"2021","unstructured":"Liu W.; Wang Y.; Chen J.; Lin Z.; Lin M.; Lin X.; Fan Y.; Beneficial effects of gracillin from Rhizoma paridis against gastric carcinoma via the potential TIPE2-mediated induction of endogenous apoptosis and inhibition of migration in BGC823 cells. Front Pharmacol 2021,12,669199","journal-title":"Front Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12967-018-1383-0","volume":"16","author":"Zhu L.","year":"2018","unstructured":"Zhu L.; Zhang X.; Fu X.; Li Z.; Sun Z.; Wu J.; Wang X.; Wang F.; Li X.; Niu S.; Ding M.; Yang Z.; Yang W.; Yin M.; Zhang L.; Zhang M.; TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt\/\u03b2-catenin pathway. J Transl Med 2018,16(1),7","journal-title":"J Transl Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10863-020-09840-w","volume":"52","author":"Zhao L.L.","year":"2020","unstructured":"Zhao L.L.; TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3+ regulatory T cells. J Bioenerg Biomembr 2020,52(4),279-289","journal-title":"J Bioenerg Biomembr"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/humrep\/deaa062","volume":"35","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Wang X.; Wan L.; Liu X.; Yu H.; Zhang D.; Sun Y.; Shi Y.; Zhang L.; Zhou H.; Wang J.; Wei Z.; TIPE2 inhibits the migra-tion and invasion of endometrial cells by targeting \u03b2-catenin to reverse epithelial-mesenchymal transition. Hum Reprod 2020,35(6),1377-1390","journal-title":"Hum Reprod"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13578-018-0247-x","volume":"8","author":"Jia W.","year":"2018","unstructured":"Jia W.; Li Z.; Chen J.; Sun L.; Liu C.; Wang S.; Chi J.; Niu J.; Lai H.; TIPE2 acts as a biomarker for tumor aggressiveness and sup-presses cell invasiveness in papillary thyroid cancer (PTC). Cell Biosci 2018,8,49","journal-title":"Cell Biosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/jcmm.14065","volume":"23","author":"Wu D.D.","year":"2019","unstructured":"Wu D.D.; Liu S.Y.; Gao Y.R.; Lu D.; Hong Y.; Chen Y.G.; Dong P.Z.; Wang D.Y.; Li T.; Li H.M.; Ren Z.G.; Guo J.C.; He F.; Ren X.Q.; Sun S.Y.; Duan S.F.; Ji X.Y.; Tumour necrosis factor-\u03b1-induced protein 8-like 2 is a novel regulator of proliferation, migration, and invasion in human rectal adenocarcinoma cells. J Cell Mol Med 2019,23(3),1698-1713","journal-title":"J Cell Mol Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"120118","DOI":"10.1016\/j.lfs.2021.120118","volume":"287","author":"Padmavathi G.","year":"2021","unstructured":"Padmavathi G.; Monisha J.; Bordoloi D.; Banik K.; Roy N.K.; Girisa S.; Singh A.K.; Longkumer I.; Baruah M.N.; Kunnumakkara A.B.; Tumor necrosis factor-\u03b1 induced protein 8 (TNFAIP8\/TIPE) family is differentially expressed in oral cancer and regulates tumor-igenesis through Akt\/mTOR\/STAT3 signaling cascade. Life Sci 2021,287,120118","journal-title":"Life Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41419-021-04289-0","volume":"12","author":"Li Y.","year":"2021","unstructured":"Li Y.; Zhang N.; Ma C.; Xu W.; Jin G.; Zheng Y.; Zhang L.; Liu B.; Gao C.; Liu S.; The overexpression of Tipe2 in CRC cells sup-presses survival while endogenous Tipe2 accelerates AOM\/DSS induced-tumor initiation. Cell Death Dis 2021,12(11),1001","journal-title":"Cell Death Dis"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203723666220727090317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207028\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203723666220727090317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T14:52:43Z","timestamp":1668178363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207028\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203723666220727090317","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}